Q3 2024 CME Group Inc Earnings Call

In This Article:

Participants

Adam Minick; Executive Director of Investor Relations; CME Group Inc

Terrence Duffy; Executive Chairman of the Board, Chief Executive Officer; CME Group Inc

Lynne Fitzpatrick; Chief Financial Officer; CME Group Inc

Suzanne Sprague; Senior Managing Director - Global Head of Clearing and Post-Trade Services for CME Group; CME Group Inc

Julie Winkler; Senior Managing Director - Chief Commercial Officer; CME Group Inc

Michael Dennis; Director; CME Group Inc

Tim Mccourt; Senior Managing Director, Global Head of Equity, FX Products, Rates, Financial and OTC Products; CME Group Inc

Derek Sammann; Senior Managing Director - Global Head of Commodities and Options and International Markets; CME Group Inc

Dan Fannon; Analyst; Jefferies LLC

Chris Allen; Analyst; Citi

Ben Budish; Analyst; Barclays

Ken Worthington; Analyst; J.P. Morgan Securities LLC

Patrick Moley; Analyst; Piper Sandler & Co

Alex Kramm; Analyst; UBS

Kyle Voigt; Analyst; Keefe, Bruyette & Woods, Inc.

Brian Bedell; Analyst; Deutsche Bank

Craig Siegenthaler; Analyst; BofA Global Research

Owen Lau; Analyst; Oppenheimer & Co. Inc.

Mike Cyprys; Analyst; Morgan Stanley & Co. LLC

Bill Katz; Analyst; TD Cowen

Presentation

Operator

Welcome to the CME Group third-quarter 2024 earnings call. (Operator Instructions) I would now like to turn the call over to Adam Minick. Please go ahead.

Adam Minick

Good morning. I hope you're all doing well today. We released our executive commentary earlier this morning, which provides extensive details on the third-quarter 2024, which we will be discussing on this call. I'll start with the Safe Harbor language, and then I'll turn it over to Terry.
Statements made on this call and in the other reference documents on our website that are not historical facts are forward-looking statements. These statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions that are difficult to predict.
Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statement. Detailed information about factors that may affect our performance can be found in the filings with the SEC, which are on our website. Lastly, on the final page of the earnings release, you will see a reconciliation between GAAP and non-GAAP measures.
With that, I'll turn the call over to Terry.

Terrence Duffy

Thanks, Adam, and thank you, all, for joining us this morning. I'm going to make a few brief comments about the quarter and the overall environment. Following that, Lynne will provide an overview of our third-quarter financial results.
In addition to Lynne, we have other members of our management team present to answer questions after the prepared remarks. Our record-breaking performance in the third quarter demonstrated the continued growing need for risk management globally.
The third-quarter average daily volume of 28.3 million contracts was the highest quarterly ADV in CME Group's history and increased 27% compared to the same period last year. This strong growth was broad-based. We achieved year-over-year growth in both volume and open interest across every asset class for the second consecutive quarter.
In aggregate, our financial products volume grew by 28%, and our commodity sector volumes grew by 20%. This record volume was aided by the effectiveness of our volume tiers, including a 36% year-over-year growth in our interest rate complex to 14.9 million contracts a day, with all-time record volume levels for both SOFR, futures, and treasuries.
We achieved this growth without lowering any fees or introducing any new incentive programs for these products. The lower RPC was driven by increased trading volume and are focused on tiering allowed our incremental earnings growth, given the operating leverage in our model.
Our SOFR complex traded over 5.9 million contracts per day in the quarter and 6.9 million per day in September, all while seeing the customer network broaden with large open interest holders reaching a new record high in September. As you know, we often hear the view that a rising Fed rate environment is best for CME's interest rate volumes.
However, over the last year, there have been no Fed rate hikes and one rate cut. And our interest rate complex grew 17% over the prior year, which had six rate hikes totaling 2.25%. Opposing views of potential and actual Fed rate changes, combined with ongoing levels of issuance and deficit financing, should continue to provide tailwinds for interest rate trading.
The uncertainty around the US election and geopolitical events around the world also contribute to a growing need for liquid and efficient markets to manage these risks in interest rates and across all of our asset classes. Q3 was also a record quarter for our international business, where average daily volume reached 8.4 million contracts, up 29% versus last year.
This was led by a record 6.2 million average daily volume for EMEA, which was up 30%, and 1.9 million contracts per day in APAC or up 28%. The record international volume was driven by growth in all six asset classes in both EMEA and APAC, with the highest volumes coming from interest rates and equity products.
In addition to the impressive volume results, we delivered record financial results for the second consecutive quarter. With that short summary, I will now turn the call over to Lynne to review these results in more detail.